UnTWISTing intestinal fibrosis: single-cell transcriptomics deciphers fibroblast heterogeneity, uncovers molecular pathways, and identifies therapeutic targets
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci184112 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Giovanni Santacroce und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Fibrosis, Fibroblasts, Twist-Related Protein 1, Single-Cell Analysis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intestinal fibrosis is a severe complication of Crohn’s disease, often requiring surgical intervention. Despite extensive research efforts, an effective treatment to prevent or reverse intestinal fibrosis remains elusive. In this issue of the JCI , Zhang, Wang, and colleagues employed single-cell RNA sequencing to uncover mechanisms of the fibrotic process. They identified a key fibroblast subset of TWIST1 + FAP + cells that interacts with CXCL9 + macrophages. TWIST1 emerged as a central regulator of the fibrotic microenvironment, representing a promising therapeutic target for effectively treating intestinal fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Santacroce, G., & Di Sabatino, A. (2024). UnTWISTing intestinal fibrosis: single-cell transcriptomics deciphers fibroblast heterogeneity, uncovers molecular pathways, and identifies therapeutic targets. Journal of Clinical Investigation. https://doi.org/10.1172/jci184112
Vancouver
Santacroce G, Di Sabatino A. UnTWISTing intestinal fibrosis: single-cell transcriptomics deciphers fibroblast heterogeneity, uncovers molecular pathways, and identifies therapeutic targets. Journal of Clinical Investigation. 2024. doi:10.1172/jci184112
BibTeX
@article{Santacroce2024,
author = {Santacroce, Giovanni and Di Sabatino, Antonio},
title = {UnTWISTing intestinal fibrosis: single-cell transcriptomics deciphers fibroblast heterogeneity, uncovers molecular pathways, and identifies therapeutic targets},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci184112}
}
EUVIMED